Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 194318
U.S. Patent Nos. 6,821,975 (expiring November 19, 2020) (â€œ975â€) and 7,182,958 (expiring April 26, 2020) (â€œ958â€)
IPSCIO Record ID: 28029
Compound shall mean the bulk active pharmaceutical ingredient tadalafil.
Pulmonary Arterial Hypertension or PAH shall mean all WHO classifications of pulmonary arterial hypertension identified in the Venice 2003 Revised Classification system.
Protocol H6D-MC-LVGX(f) An Extension Study to Evaluate the Long-Term Safety and Efficacy of the Phosphodiesterase Type 5 (PDE5) Inhibitor Tadalafil in the Treatment of Patients with Pulmonary Arterial Hypertension.
5,859,006, Granted January, 12, 1999
6,821,975, Granted November 23, 2004
7, 182, 958, Granted February 27, 2007
US Application 10/521,393
IPSCIO Record ID: 277861